Commentary: Do we all have Alzheimer’s? Drug makers might want you to think so

This month, the Food and Drug Administration changed the label for the recently approved Alzheimers treatment aducanumab sold under the brand name Aduhelm to specify that the controversial drug made … Read full article

Leave a comment

Your email address will not be published. Required fields are marked *